Polyclonal Antibody to Complement Component 4 (C4)
- Product No.PAA888Ga01
 - Organism SpeciesChicken (Gallus) Same name, Different species.
 - SourcePolyclonal antibody preparation
 - HostRabbit
 - Potencyn/a
 - Ig Type IgG
 - PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
 - LabelNone
 - Immunogen RPA888Ga01-Recombinant Complement Component 4 (C4)
 - Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
 - TraitsLiquid
 - Concentration500µg/mL
 - Organism Species Moren/a
 - ApplicationsWB
If the antibody is used in flow cytometry, please check FCM antibodies. - DownloadInstruction Manual
 - UOM 20µl100µl 200µl 1ml 10ml
 - FOB
    
                                    US$ 103 
            
                
                        US$ 239 
                                        US$ 342 
                                        US$ 855 
                                        US$ 3420 
                            
For more details, please contact local distributors! 
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against C4. It has been selected for its ability to recognize C4 in immunohistochemical staining and western blotting.
USAGE
        Western blotting: 0.5-5µg/mL;
Immunohistochemistry: 5-50µg/mL;
Immunocytochemistry: 5-50µg/mL;
Optimal working dilutions must be determined by end user.    
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations | 
| Journal of Clinical Immunology | Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. PubMed: 22941511 | 
| British Journal of Pharmacology | The suppression of Brd4 inhibits peripheral plasma cell differentiation and exhibits therapeutic potential for systemic lupus erythematosus | 
| Catalog No. | Related products for research use of Chicken (Gallus) Organism species | Applications (RESEARCH USE ONLY!) | 
| RPA888Ga01 | Recombinant Complement Component 4 (C4) | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA888Ga01 | Polyclonal Antibody to Complement Component 4 (C4) | WB | 
        
                            
                            
